Identification of genes and pathways related with cerebral small vessel disease based on a long non-coding RNA-mediated, competitive endogenous RNA network

Yan,Hui; Yang,Xiaoli; Zhao,Xueman; Wang,Huankun

doi:10.3892/etm.2018.6148

Identification of genes and pathways related with cerebral small vessel disease based on a long non-coding RNA-mediated, competitive endogenous RNA network

Authors:
- Hui Yan
- Xiaoli Yang
- Xueman Zhao
- Huankun Wang
View Affiliations

Affiliations: Department of Neurology, The People's Hospital of Yucheng, Yucheng, Dezhou, Shandong 251200, P.R. China
Published online on: May 10, 2018 https://doi.org/10.3892/etm.2018.6148
Pages: 121-126

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

This study aimed to investigate the cerebral small vessel disease (SVD), an intrinsic disorder of the brain's perforating arterioles, which could cause serious cognitive decreasing and trigger dementia. In this study, we present a multi-step computational approach to construct a functional SVD long non-coding RNA (lncRNA)-mediated ceRNA network (LMCN) by integrating genome-wide lncRNA and mRNA expression profiles, miRNA-target interactions, and functional analyses. We used hypergeometric test to evaluate enrichment significance of miRNAs and we obtained the LMCN, which contained 27 lncRNAs, 7,229 mRNA, and 28,871 lncRNAs-mRNA interrelationship pairs. What's more, co-expression analysis was utilized to constructe a competitive endogenous RNAs (ceRNAs) interaction network which comprised of 21 lncRNAs, 129 mRNAs and 141 interaction pairs. We determined that metastasis-associated lung adenocarcinoma transcript 1 and MIR155 host gene acted synergistically to regulate mRNAs in a network module of the competitive LMCN. Moreover, 7 genes were obtained through Gene Ontology enrichment. In addition, 29 mRNA enriched pathways significantly associated with lncRNAs was obtained via Fisher test. In conclusion, we identified 7 potential lncRNAs and 29 possible lncRNA-mediated pathways associated with SVD. Thus, ceRNAs could accelerate biomarker discovery and therapeutic development in SVD.

View Figures

View References

1	Pantoni L: Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9:689–701. 2010. View Article : Google Scholar : PubMed/NCBI
2	Wardlaw JM, Smith C and Dichgans M: Mechanisms of sporadic cerebral small vessel disease: Insights from neuroimaging. Lancet Neurol. 12:483–497. 2013. View Article : Google Scholar : PubMed/NCBI
3	van der Flier WM, van Straaten EC, Barkhof F, Verdelho A, Madureira S, Pantoni L, Inzitari D, Erkinjuntti T, Crisby M, Waldemar G, et al: Small vessel disease and general cognitive function in nondisabled elderly: The LADIS study. Stroke. 36:2116–2120. 2005. View Article : Google Scholar : PubMed/NCBI
4	Pantoni L, Sarti C, Alafuzoff I, Jellinger K, Munoz DG, Ogata J and Palumbo V: Postmortem examination of vascular lesions in cognitive impairment: A survey among neuropathological services. Stroke. 37:1005–1009. 2006. View Article : Google Scholar : PubMed/NCBI
5	Hu X, De Silva TM, Chen J and Faraci FM: Cerebral vascular disease and neurovascular injury in ischemic stroke. Circ Res. 120:449–471. 2017. View Article : Google Scholar : PubMed/NCBI
6	Lammie GA, Brannan F, Slattery J and Warlow C: Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke. 28:2222–2229. 1997. View Article : Google Scholar : PubMed/NCBI
7	Dalkara T and Alarcon-Martinez L: Cerebral microvascular pericytes and neurogliovascular signaling in health and disease. Brain Res. 1623:3–17. 2015. View Article : Google Scholar : PubMed/NCBI
8	Das S, Ghosal S, Sen R and Chakrabarti J: lnCeDB: Database of human long noncoding RNA acting as competing endogenous RNA. PLoS One. 9:e989652014. View Article : Google Scholar : PubMed/NCBI
9	Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, Margulies EH, Weng Z, Snyder M, Dermitzakis ET, Thurman RE, et al: Children's Hospital Oakland Research Institute: Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 447:799–816. 2007. View Article : Google Scholar : PubMed/NCBI
10	Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermüller J, Hofacker IL, et al: RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science. 316:1484–1488. 2007. View Article : Google Scholar : PubMed/NCBI
11	Ponting CP, Oliver PL and Reik W: Evolution and functions of long noncoding RNAs. Cell. 136:629–641. 2009. View Article : Google Scholar : PubMed/NCBI
12	Guo X, Gao L, Wang Y, Chiu DK, Wang T and Deng Y: Advances in long noncoding RNAs: Identification, structure prediction and function annotation. Brief Funct Genomics. 15:38–46. 2016. View Article : Google Scholar : PubMed/NCBI
13	Martianov I, Ramadass A, Barros Serra A, Chow N and Akoulitchev A: Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript. Nature. 445:666–670. 2007. View Article : Google Scholar : PubMed/NCBI
14	Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, et al: Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323. 2007. View Article : Google Scholar : PubMed/NCBI
15	Zhang Y, Tao Y and Liao Q: Long noncoding RNA: A crosslink in biological regulatory network. Brief Bioinform. Apr 24–2017.(Epub ahead of print).
16	Jin G, Sun J, Isaacs SD, Wiley KE, Kim ST, Chu LW, Zhang Z, Zhao H, Zheng SL, Isaacs WB, et al: Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carcinogenesis. 32:1655–1659. 2011. View Article : Google Scholar : PubMed/NCBI
17	Liu SP, Yang JX, Cao DY and Shen K: Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biol Med. 10:138–141. 2013.PubMed/NCBI
18	Kartha RV and Subramanian S: Competing endogenous RNAs (ceRNAs): New entrants to the intricacies of gene regulation. Front Genet. 5:82014. View Article : Google Scholar : PubMed/NCBI
19	Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
20	Tay Y, Rinn J and Pandolfi PP: The multilayered complexity of ceRNA crosstalk and competition. Nature. 505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
21	Zhou X, Liu J and Wang W: Construction and investigation of breast-cancer-specific ceRNA network based on the mRNA and miRNA expression data. IET Syst Biol. 8:96–103. 2014. View Article : Google Scholar : PubMed/NCBI
22	Zhou M, Wang X, Shi H, Cheng L, Wang Z, Zhao H, Yang L and Sun J: Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer. Oncotarget. 7:12598–12611. 2016.PubMed/NCBI
23	Cao Y, Wang P, Ning S, Xiao W, Xiao B and Li X: Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network. Oncotarget. 7:41737–41747. 2016. View Article : Google Scholar : PubMed/NCBI
24	Paraskevopoulou MD, Georgakilas G, Kostoulas N, Reczko M, Maragkakis M, Dalamagas TM and Hatzigeorgiou AG: DIANA-LncBase: Experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res. 41(D1): D239–D245. 2013. View Article : Google Scholar : PubMed/NCBI
25	Li JH, Liu S, Zhou H, Qu LH and Yang JH: starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42(D1): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
26	Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao Z, Zhi H, Wang T, Guo Z and Li X: Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer. Nucleic Acids Res. 43:3478–3489. 2015. View Article : Google Scholar : PubMed/NCBI
27	Li Y, Bao C, Gu S, Ye D, Jing F, Fan C, Jin M and Chen K: Associations between novel genetic variants in the promoter region of MALAT1and risk of colorectal cancer. Oncotarget. 8:92604–92614. 2017.PubMed/NCBI
28	Wu X, Wang Y, Yu T, Nie E, Hu Q, Wu W, Zhi T, Jiang K, Wang X, Lu X, et al: Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma. Neuro-oncol. 19:1195–1205. 2017. View Article : Google Scholar : PubMed/NCBI
29	Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI